168.10
-0.79 (-0.47%)
-0.79 (-0.47%)
Upgrade to Real-Time
Afterhours (Closed)
Volume | 6,158,105 |
|
|||||
News | - | ||||||
Day High | 168.866 | Low High |
|||||
Day Low | 167.77 |
Stock Name | Stock Symbol | Market | Stock Type |
---|---|---|---|
Johnson and Johnson | JNJ | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
168.56 | 167.77 | 168.866 | 168.23 | 168.89 |
Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
76,961 | 6,158,105 | US$ 168.42 | US$ 1,037,135,174 | - | 155.72 - 186.69 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:59:30 | 3 | US$ 168.10 | USD |
Johnson and Johnson Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 439.49B | 2.61B | 2.61B | US$ 94.94B | US$ 17.94B | 6.74 | 25.10 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | US$ 4.45 | 2.68% | 02/17/23 | -400.34k | 0.20% |
Johnson and Johnson News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 170.43 | 175.00 | 166.01 | 168.70 | 8,404,113 | -2.33 | -1.37% |
1 Month | 177.49 | 180.93 | 166.01 | 173.12 | 6,899,326 | -9.39 | -5.29% |
3 Months | 171.56 | 181.039 | 166.01 | 174.98 | 6,504,144 | -3.46 | -2.02% |
6 Months | 172.92 | 181.039 | 159.17 | 170.33 | 6,810,067 | -4.82 | -2.79% |
1 Year | 169.39 | 186.69 | 155.72 | 172.68 | 7,172,246 | -1.29 | -0.76% |
3 Years | 147.22 | 186.69 | 109.16 | 160.19 | 7,463,173 | 20.88 | 14.18% |
5 Years | 144.85 | 186.69 | 109.16 | 150.22 | 7,266,163 | 23.25 | 16.05% |
Johnson and Johnson Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States. |